Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/29/2003CA2382470A1 Mutant ndp kinases for antiviral nucleotide analog activation and therapeutic uses thereof
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6639014 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/28/2003US6638768 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638764 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638756 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6638264 Perfusion apparatus and methods for pharmaceutical delivery
10/28/2003CA2249448C Egg anti-inflammatory composition, method of isolation and use
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087834A2 High throughput analysis of recombinant proteins in multi-well plates
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087382A1 Adeno-associated virus producer system
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087336A2 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
10/23/2003WO2003087334A2 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit
10/23/2003WO2003087325A2 Methods and compositions for preventing and treating microbial infections
10/23/2003WO2003087324A2 Antibody gene transfer and recombinant aav
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087320A2 Antagonists of il-21 and modulation of il-21-mediated t cell responses
10/23/2003WO2003087311A2 PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
10/23/2003WO2003087294A2 Recombining viral vectors for the tetracycline-regulated expression of genes
10/23/2003WO2003087158A2 Regulation of human transient receptor potential channel
10/23/2003WO2003087154A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003087153A1 Mouse kruppel-type zinc finger protein knox-25 and the use of thereof
10/23/2003WO2003087135A2 Novel pheromone receptor
10/23/2003WO2003087128A2 Secretory signal sequences and uses thereof
10/23/2003WO2003087122A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086450A1 Active antiangiogenic therapy
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086276A2 Compositions and methods for portal specific gene delivery and treatment of infection
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003072812A3 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/23/2003WO2003062373A9 Methods and materials for the recruitment of endothelial cells
10/23/2003WO2003057898A3 Methods and materials for modulating p2x2
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003054005A3 Bone polypeptide-1
10/23/2003WO2003047518A3 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof
10/23/2003WO2003014307A3 Antisense modulation of apolipoprotein(a) expression
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2003006654A3 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
10/23/2003WO2003002602A3 Nogo and nogo receptor derived peptides for t-cell mediated neuroprotection
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002081745A3 Genes involved in osteogenesis, and methods of use
10/23/2003WO2002081518A3 Proteins, polynucleotides encoding them and methods of using the same
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001094560A3 In vitro assembly of sv40 viruses and pseudoviruses
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001029232A8 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001000879A8 Novel kinases and uses thereof
10/23/2003US20030199516 Methods of treating infection by drug resistant bacteria
10/23/2003US20030199472 Administering to the patient an effective amount of an expression construct comprising nucleic acid comprising a sequence encoding a modified estrogen receptor, wherein sequence is under control of promoter
10/23/2003US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products
10/23/2003US20030199468 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences
10/23/2003US20030199465 For detection and therapy of a broad range of pathological states
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199462 Methods and compositions for regulating cellular signaling
10/23/2003US20030199447 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199093 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells
10/23/2003US20030199090 Compositions and methods for drug delivery using pH sensitive molecules
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199022 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression
10/23/2003US20030199009 Modifications of apoptin
10/23/2003US20030199002 For the treatment, management, or prevention of disorders associated with abnormal expression and/ or activity of clk-2 (clock-2) nucleic acids; treating or preventing disorders associated with decreased/increased apoptosis e.g. cancer
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 870